The oncogenic transcription factor MYC drives the rewiring of multiple metabolic pathways in a broad spectrum of cancers, enhancing glycolysis, glutaminolysis, oxidative phosphorylation (OXPHOS), and nucleotide and amino acid synthesis [4,5,6,7]. Here, MYC is linked to cancer.